Search

Russo's New York Pizzeria Kicks Off Fundraiser for Life-Saving Cancer Research

RUSSO'S NEW YORK PIZZERIA KICKS OFF FUNDRAISER FOR LIFE-SAVING CANCER RESEARCH

Authentic New York-style Pizza Restaurant Launches Brand-wide Fundraising Campaign to Benefit Leukemia & Lymphoma Society Houston,...

 
 
 
Every New FDA Drug Approval in 2017

EVERY NEW FDA DRUG APPROVAL IN 2017

2017 was a busy year for the FDA. With 46 approvals, the year far outpaced the 22 approvals in 2016. We've already shown you every...

Physical Activity can Improve Lymphoma Patient's Chances of Survival

PHYSICAL ACTIVITY CAN IMPROVE LYMPHOMA PATIENT'S CHANCES OF SURVIVAL

Lymphoma patient's chances of survival can be improved by good physical activity and thereby physicians have to counsel patients to...

 
 
 

PHASE 2 DATA FOR ROCHE'S LYMPHOMA ADC DOESN'T DISAPPOINT

With breakthrough designation from the FDA and priority medicine status in the EU, expectations for Roche's antibody-drug conjugate...

CAR T Therapy, New Treatment for Non-Hodgkin's Lymphoma

CAR T THERAPY, NEW TREATMENT FOR NON-HODGKIN'S LYMPHOMA

A new therapy has been developed that is highly durable can fight against non-Hodgkin's lymphoma diagnosed in about 56,000 people every...

 
 
 
 
 
 

HASHCLONE: A NEW TOOL TO QUANTIFY THE MINIMAL RESIDUAL DISEASE IN B-CELL LYMPHOMA FROM DEEP SEQUENCING DATA

Mantle Cell Lymphoma is a B cell aggressive neoplasia accounting for about the 6% of all lymphomas. The most common molecular marker...

At Seattle Children's, Another Piece of Ambitious CAR-T Plan in Place

AT SEATTLE CHILDREN'S, ANOTHER PIECE OF AMBITIOUS CAR-T PLAN IN PLACE

The researchers and doctors at Seattle Children's are embarking upon a complicated quest, involving multiple clinical studies of cutting-edge...

 
 
 
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOS & More

BIOTECH ROUNDUP: OPIOID NEWS, ASH PREVIEW, BOSTON BIO IPOS & MORE

The rising death toll from opioids has prompted policymakers to try various ways to take on the problem. President Trump's opioid commission...

 
 
 
US regulators approve 2nd gene therapy for blood cancer

US REGULATORS APPROVE 2ND GENE THERAPY FOR BLOOD CANCER

TRENTON, N.J. - U.S. regulators have approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive...

 
 
 
A cancer treatment that's part of 'a big new field of medicine' just got approved

A CANCER TREATMENT THAT'S PART OF 'A BIG NEW FIELD OF MEDICINE' JUST GOT APPROVED

The FDA just approved another revolutionary cancer treatment. The treatment, called Yescarta, treats a type of blood cancer called...

Child model fronted campaigns before her cancer diagnosis

CHILD MODEL FRONTED CAMPAIGNS BEFORE HER CANCER DIAGNOSIS

Daisy O'Leary Pye, 12, from Lee, south-east London, was diagnosed with Hodgkin's lymphoma, a type of cancer that develops in the lymphatic...

 
 
 
Helmut's Fight with T-Cell Lymphoma: Can You Help?

HELMUT'S FIGHT WITH T-CELL LYMPHOMA: CAN YOU HELP?

By Candace Escobar Helmut is my heart dog. He is nine years old, loving guy. Helmut has t-cell lymphoma, an unfortunate curse of his...

Chimera Viruses may Help Fight Against Lymphomas

CHIMERA VIRUSES MAY HELP FIGHT AGAINST LYMPHOMAS

Chimera virus that allows the study of molecules to treat cancers caused by human herpes virus infection. Chimera viruses can help...

 
 
 
Bio Roundup: CAR-T's Huge Week, Merck's ‘Pib Choice & More

BIO ROUNDUP: CAR-T'S HUGE WEEK, MERCK'S ‘PIB CHOICE & MORE

The far-out idea of reprogramming a patient's immune cells to fight cancer, known as CAR-T, entered the mainstream this week, and two...

‘Historic' first-of-its-kind ‘living drug' for childhood leukemia approved

‘HISTORIC' FIRST-OF-ITS-KIND ‘LIVING DRUG' FOR CHILDHOOD LEUKEMIA APPROVED

The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients'...